3-5 December 2019 | San Francisco
Integrating the technologies revolutionising
immunotherapy and its impact on
vaccines development
500+ Attendees | 200+ Speakers | 4 Streams |
85% Decision Makers
This is the congress for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and partnering.
2019 Advisory Board
Dr Biol. Sci. Alessandro Sette
Center Head, Division Head, and Professor Center for Infectious Disease
La Jolla Institute
Dr Ezra Cohen
Professor of Medicine, UC San Diego Moores Cancer Center and Co-Director
San Diego Center for Precision Immunotherapy
Dr Peter Hotez MD PhD
Dean of the National School of Tropical Medicine
Baylor College of Medicine
Dr Karin Jooss
Executive Vice President of Research, and Chief Scientific Officer
Gritstone Oncology
Dr Jerald Sadoff
Senior Advisor
Janssen Infectious Diseases and Vaccines
Prof Bali Pulendran
Professor in the Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Dr Roy Baynes
Senior Vice President, Global Clinical Development and Chief Medical Officer
Merck Research Laboratories
Dr. Wayne C. Koff
President and CEO
The Human Vaccines Project
Dr Maria Karasarides
Executive Director, ImmunoOncology
Regeneron Pharmaceuticals
It was honestly one of the best conferences that I’ve ever been to
Senior Research Associate, Dendreon
2018 Key Speakers
- Dr Ezra CohenAssociate Director of Moores Cancer CenterU.C. San Diego Moores Cancer CenterDr David GorskiManaging Editor, Science Based Medicine; Professor and Chief, Breast Surgery SectionWayne State University School of Medicine
- Dr Peter HotezDean, National School of Tropical Medicine, Director, Texas Children’s Hospital CenterBaylor College of MedicineDr Larry SmarrFounding DirectorCalit2
- Dr Nancy ValenteVice President, Global Product Development, Hematology/Oncology; Head Hematology DevelopmentGenentechDr Travis YoungVice President, BiologicsCalifornia Institute for Biomedical Research
- Robb ButlerFormer Programme Manager, Social ScientistWhoDr Ho ChoVP, Biotherapeutics Executive ResearchCelgene
- Dr Eve DubéResearcher, Quebec National Institute of Public Health; Invited professor,Universite LavalDr Sergei GleyzerResearch Associate, Department of Physics, University of Florida; Coordinator of the LHC Machine-Learning Working GroupCern
- Dr Catherine HigginsDirector of Scientific Program ManagementStand Up To CancerDr Eva LeeProfessor, Center for Bioinformatics and Computational GenomicsGeorgia Institute of Technology
- Dr Richard PanState SenatorCalifornia Senate, District 6Min SongProgram Director, Cancer Therapy Evaluation Program, Cancer Moonshot Implementation Team,National Institutes of Health
- Dr Theresa LavalleeHead of Translational MedicineParker Institute for Cancer ImmunotherapyDr Darrick CarterVice President - Adjuvant TechnologyI.D.R.I.
- Dr Danilo CasimiroVP & Head, External R&D and Vaccine PlatformsSanofi PasteurDr Grace ChenDeputy Chief of the Clinical Trials Program in the VRCNational Institutes of Health
- Dr Ann GinsbergSenior Technical AdvisorInternational AIDS Vaccine Initiative (IAVI)Dr Paul MaffuidEVP Research and DevelopmentMabVax Therapeutics Inc
- Dr Arturo MolinaChief Medical OfficerSutro BiopharmaPeter NaraChairman EmeritusBiological Mimetics, Inc.
- Dr Melanie SavilleDirector Vaccine DevelopmentCEPIDr Ron BabecoffFounder, President & CEOBiondVax Pharmaceuticals Ltd
- Dr Sylvaine CasesVP, Oncology Scientific InnovationJanssen Research & DevelopmentDr John DesjarlaisSenior Vice President of Research and Chief Scientific OfficerXencor, Inc.
- Dr Swati GuptaVice President, Research Integration & InnovationInternational Aids Vaccine InitiativeDr Kristen HegeCorporate Vice President, Translational Development, Hematology/OncologyCelgene
- Dr Stephen HoffmanChief Executive and Scientific OfficerSanariaDr Victor NizetProfessor of Pediatrics and Pharmacy, Chief of the Division of Host-Microbe Systems and TherapeuticsUniversity of California San Diego
- Dr Elizabeth TrehuChief Medical OfficerJounce TherapeuticsDr Bob ValamehrVice President of Cancer ImmunotherapyFate Therapeutics
- Dr Steve CoatsVice President External Science StrategyMedImmune IncDr James CroweDirector of Vanderbilt Vaccine CenterVanderbilt Vaccine Center
- Dr Barry DatlofChief, Business Development and CommercializationU.S. Army Medical Research and Materiel CommandDr Anna DurbinAssociate ProfessorJohns Hopkins Bloomberg School of Public Health
- Dr Bruce GellinPresident, Global ImmunizationSabin Vaccine InstituteDr Farshad GuirakhoocsoGeoVax, Inc.
- Dr Cristian MassacesiVice President, Immuno-Oncology Medicine Team LeaderPfizerDr Michael MowattDirector, Technology Transfer and Intellectual Property OfficeNational Institute of Allergy and Infectious Diseases
- Dr Keith RubinCEOILiAD Biotechnologies, LLCDr Theodore TsaiVice President of Immunizations science and PolicyTakeda Vaccines
2019 Sponsors & Exhibitors
Silver Sponsor
Bronze Sponsor
Silver Sponsor
Bronze Sponsor
Company Showcase Sponsor
Exhibitor
Exhibitor
Exhibitor
Discover an opportunity
The World Vaccine & Immunotherapy Congress West Coast offers outstanding opportunities for service and solution providers to the vaccine industry, from senior sponsorship to exhibition booths. If you are looking to access senior decision makers of the vaccine community, this is your best ROI opportunity in 2019.
SEE YOU IN SAN FRANCISCO DECEMBER 2019!
MARK YOUR CALENDARS NOW
Sign Up for Event Updates
Contact us
To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156
oliver.breed@terrapinn.com
To speak:
Lauren Sheppard
+44 (0)207 092 1211
lauren.sheppard@terrapinn.com
Organiser
